Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000749647-10-000048
Filing Date
2010-09-22
Accepted
2010-09-22 17:08:23
Documents
1
Period of Report
2010-09-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4544
  Complete submission text file 0000749647-10-000048.txt   6545
Mailing Address 10220 OLD COLUMBIA ROAD SUITE L COLUMBIA MD 21046
Business Address 10220 OLD COLUMBIA ROAD SUITE L COLUMBIA MD 21046-1705 4102905390
Celsion CORP (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MOLECULAR INSIGHT PHARMACEUTICALS, INC. 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
Borys Nicholas (Reporting) CIK: 0001388138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 101085119